Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
Patients with rheumatoid arthritis (RA) are at approximately 1.5-fold risk of atherosclerotic cardiovascular disease (CVD) compared with the general population, a phenomenon resulting from combined effects of traditional CVD risk factors and systemic inflammation. Rheumatoid synovitis and unstable a...
Guardado en:
Autores principales: | Anne Mirjam Kerola, Silvia Rollefstad, Anne Grete Semb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e08fa4ce7c8a4d51b25860323e4e554a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020) -
Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021) -
Pathways by Which Food Insecurity Is Associated With Atherosclerotic Cardiovascular Disease Risk
por: Deepak Palakshappa, et al.
Publicado: (2021) -
Use of the Orbital Atherectomy System in Isolated, Chronic Atherosclerotic Lesions of the Popliteal Artery
por: Patricia Torres Lebruno, et al.
Publicado: (2020) -
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Shahnam Sharif, et al.
Publicado: (2021)